Evidence map›Paper›PMID 41532837›Full record

Trial reportSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2026

A Split Face Study Comparing the Effect of a PDLLA Based Product and PLLA on the Nasolabial Fold (NLF).

Je-Young Park, Dong Jin Im, Hee Dae Jeon, Hyun Jo Kim, Do Young Rhee, BonCheol Leo Goo, Kwang Ho Han, Zhongfan Chang, Hei Sung Kim

Abstract readMulticenter StudyRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. A Split Face Study Comparing the Effect of a PDLLA Based Product and PLLA on the Nasolabial Fold (NLF).Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Je-Young ParkApgujeong Oracle Dermatology Clinic, Seoul, South Korea.
Dong Jin ImLisienne Dermatology Clinic, Gyeonggi-do, South Korea.
Hee Dae JeonBanobagi Dermatologic Clinic, Seoul, South Korea.
Hyun Jo KimCNP Skin Clinic, Cheonan, South Korea.ORCID https://orcid.org/0000-0002-4330-2055
Do Young RheeHeal House Dermatology Clinic, Seoul, South Korea.
BonCheol Leo GooNaeum Dermatology and Aesthetics Clinic, Seoul, South Korea.ORCID https://orcid.org/0000-0002-7436-7572
Kwang Ho HanNature Dermatology Clinic, Seoul, South Korea.
Zhongfan ChangDepartment of Dermatology, Asan Medical Center, Seoul, South Korea.
Hei Sung KimDepartment of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.ORCID https://orcid.org/0000-0003-0576-0474

Funding

Vaim Co., Ltd. (Okcheon, Korea)
6 · The paper itself

Abstract

backgroundInjectable Poly-L-lactic acid (PLLA) is effective in restoring mid-face volume and is widely used treating the nasolabial fold (NLF). This study aimed to compare the safety and efficacy of a novel PDLLA based product (PDLLA + non-cross-linked HA; Poly-D, L-lactic acid + hyaluronic acid) with that of a commonly used PLLA for NLF correction.

methodsIn this multi-center, randomized, split-face, evaluator-blinded study, 33 subjects received injections of the PDLLA based product on one NLF and PLLA injection on the other (three injections total, administered at 4-week intervals). Wrinkle severity was assessed using standardized photographs taken at baseline (week 0); before the second and third injections (weeks 4 and 8); 4 weeks after the third injection (week 12); and 3 months after the final injection (week 24) using the Wrinkle Severity Rating Scale (WSRS). Safety data were collected through subject interviews and case report forms.

resultsBoth the PDLLA based product and PLLA significantly improved NLF wrinkle severity at all time points compared to baseline (p < 0.001). The degree of improvement was comparable between the two products throughout the observation period.

conclusionThe PDLLA based product demonstrated non-inferiority to PLLA for NLF correction. Further studies are needed to assess long-term safety.

Indexed as

Cosmetic TechniquesDermal FillersHyaluronic AcidNasolabial FoldPolyestersSkin AgingAdultAgedFemaleHumansMaleMiddle AgedTreatment OutcomeDermal FillersHyaluronic AcidPolyesterspoly(lactide)hyaluronic acidL‐lactic acidnasolabial foldPDLLA based productpoly‐Dpoly‐L‐lactic acid

Identifiers

PMID41532837
PMCPMC12802405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.